Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HFB200603 |
Trade Name | |
Synonyms | HFB-200603|HFB 200603 |
Drug Descriptions |
HFB200603 is a monoclonal antibody that targets BTLA, which potentially decreases tumor immune suppression (Cancer Res 2022;82(12_Suppl):Abstract nr 4248). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HFB200603 | HFB200603 | 0 | 1 |
HFB200603 + Tislelizumab | HFB200603 Tislelizumab | 0 | 1 |